Share Page:

Volume 10 , Issue 1
January/February 1995

Pages 15-21

MkII—A Modified Self-Tapping Brånemark Implant: 3-Year Results of a Controlled Prospective Pilot Study

Morgan Olsson, DDS/Bertil Friberg, DDS, MSc/Hans Nilson, DDS/ Christina Kultje, MSc

PMID: 7615313

A modified self-tapping implant (MkII) with improved cutting characteristics has been designed for use in both maxillae and mandibles. Four sequential studies were conducted to evaluate the outcome of the MkII implant compared to the standard implant. The results presented here are from the extended pilot study that has been conducted as an intra-individual study of 103 patients; ie, each patient received both test (MkII) and control (standard Brånemark System) implants. Seventy patients were treated in the mandible and 33 in the maxilla. The cumulative survival rates and marginal bone resorption showed equivalent results for both test and control implants. Three-year cumulative survival rates were 87.9% and 86.8% for test and control implants in maxillae, respectively, and 99.5% and 100% in mandibles, respectively. The mean marginal bone resorption was approximately 0.5 (control) to (MK II) 0.6 mm after 3 years of function. A total of 288 test implants and 275 control implants were placed. All implants, both test and control, could be placed in an appropriate implant position, but 21.2% of the implants were not fully seated by machine power only; the use of a manual cylinder wrench for the final turns was necessary. During the last phase of the study, however, with an increase in twist-drill diameter from 3.0 to 3.15 mm and an increased motor torque, the prerequisites of successful implant placement into final position were met. (Int J Oral Maxillofac Implants 1995;10:15–21)

Key words: Brånemark System, self-tapping implant, tapping ability

Full Text PDF File | Order Article


Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.


© 2017 Quintessence Publishing Co, Inc JOMI Home
Current Issue
Ahead of Print
Author Guidelines
Accepted Manuscripts
Submission Form
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us